Tier 3 reports for 'Amoxicillin and Clavulanic Acid Oral Suspensions' and 'powder for suspension'
Tier 3 Drug Shortages
4 reports found
Brand name | Company Name | Date Updated | Strength(s) | Status | Report ID |
---|---|---|---|---|---|
CLAVULIN 200 | GLAXOSMITHKLINE INC | 2023-03-23 | 28.5MG 200MG | Actual shortage | 171572 |
CLAVULIN 250 F ORAL SUS | GLAXOSMITHKLINE INC | 2023-03-16 | 62.5MG 250MG | Resolved | 175255 |
CLAVULIN 400 | GLAXOSMITHKLINE INC | 2023-03-16 | 400MG 57MG | Resolved | 168941 |
CLAVULIN 125 F ORAL SUS | GLAXOSMITHKLINE INC | 2023-03-15 | 125MG 31.25MG | Actual shortage | 171718 |
Showing 1 to 4 of 4
Tier 3 Drug Discontinuations
0 reports found
Brand name | Company Name | Date Updated | Strength(s) | Status | Report ID |
---|
Showing 1 to 0 of 0